Propanc Biopharma, Inc.

8-K Director or officer change Jul 14, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Director or officer change Feb 26, 2026 10-Q Quarter ended 2025-12-31 Feb 17, 2026 8-K Delisting notice or listing-rule failure Jan 7, 2026 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Unregistered sale of equity; Amended charter or bylaws Nov 10, 2025 8-K Entered a material agreement Oct 14, 2025 10-K Fiscal year ended 2025-06-30 Sep 29, 2025 8-K Entered a material agreement; Director or officer change; Other events Aug 19, 2025 8-K Director or officer change Aug 13, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jul 30, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jul 22, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 27, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 18, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 2, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity May 8, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Apr 21, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 18, 2025 10-Q Quarter ended 2024-12-31 Feb 14, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Feb 12, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Dec 20, 2024 8-K Entered a material agreement; Took on a direct financial obligation Dec 6, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 10-K Fiscal year ended 2024-06-30 Sep 30, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Sep 27, 2024 8-K Entered a material agreement; Took on a direct financial obligation Aug 30, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Aug 15, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Aug 7, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jul 2, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 21, 2024 8-K/A Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 13, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 12, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 5, 2024 8-K Entered a material agreement; Took on a direct financial obligation May 16, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Apr 22, 2024 8-K Other events Apr 10, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 11, 2024